Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Operating Activities
Net income	$ 215,859	$ 191,991
Depreciation and amortization	60,683	52,935
Stock-based compensation (Note 12)	19,260	11,350
Pension income (Note 16)	(13,134)	(10,681)
Deferred income tax benefit (Note 11)	0	(307)
Loss on asset dispositions, net	637	989
Pension contributions (Note 16)	(6,686)	(5,656)
Currency exchange losses, net	3,971	13,237
Changes in:
Trade receivables	(34,934)	(7,878)
Inventories (Note 5)	(8,090)	(23,082)
Accounts payable	22,859	5,466
Other current assets and liabilities	(8,778)	10,942
Other noncurrent assets and liabilities	1,728	2,207
Cash Flow From Operating Activities	253,375	241,513
Investing Activities
Acquisitions, net of cash acquired (Note 15)	(563,087)	(187,774)
Capital expenditures	(37,388)	(52,104)
Property disposals and other investing	36	19
Cash Flow Used in Investing Activities	(600,439)	(239,859)
Financing Activities
Proceeds from long-term debt (Note 13)	1,692,464	836,712
Payments on long-term debt (Note 13)	(1,150,006)	(721,384)
Debt issuance costs	0	(3,084)
Cash dividends paid	(62,248)	(61,638)
Company stock purchases (Note 8)	(99,306)	(50,025)
Exercise of stock options (Note 8)	26	511
Employee stock purchase plan (Note 8)	1,079	1,082
Cash Flow From Financing Activities	382,009	2,174
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(12,477)	2,002
Change in cash, cash equivalents and restricted cash	22,468	5,830
Beginning cash, cash equivalents and restricted cash	165,992	165,097
Ending cash, cash equivalents and restricted cash	188,460	170,927
Supplemental cash flow information:
Cash and cash equivalents	187,248	169,998
Restricted cash included in prepaid expenses and other current assets	1,212	929
Total cash, cash equivalents and restricted cash	$ 188,460	$ 170,927